About
Our mission
Governance
Partners
Science
Our Genome Engineering Platform
TALEN® Technology
In-House Manufacturing
Pipeline
Product Candidates
Investors
IR Overview
News
Press releases
Events and Webcasts
Presentations
Corporate presentations
Scientific presentations
Scientific publications
Corporate Governance
Board of Directors
Executive Committee
External Auditors
Governance Documents
General meetings
Financial Information
SEC filings
Financial statements
Voting Rights & Share Capital
Stock information
Shareholders Services
IR Inquiries
IR FAQ
Careers
Our culture
Job opportunities
Contact us
FR
Recherche
›
Investors
›
Scientific presentations
About
Our mission
Governance
Partners
Science
Our Genome Engineering Platform
TALEN® Technology
In-House Manufacturing
Pipeline
Product Candidates
Investors
IR Overview
News
Press releases
Events and Webcasts
Presentations
Corporate presentations
Scientific presentations
Scientific publications
Corporate Governance
Board of Directors
Executive Committee
External Auditors
Governance Documents
General meetings
Financial Information
SEC filings
Financial statements
Voting Rights & Share Capital
Stock information
Shareholders Services
IR Inquiries
IR FAQ
Careers
Our culture
Job opportunities
Contact us
FR
Scientific presentations
All
2026
2025
2024
2023
2022
2021
10
Jun 2022
17:39 E.S.T.
Pre-Clinical Proof Of Concept Demonstrates Robust Activity Of UCART20x22 Dual CAR T-Cells For The Treatment Of B-Cell Malignancies – EHA 2022- Poster Presentation
Download the PDF file
10
Jun 2022
17:35 E.S.T.
Preliminary Results from the Flu/Cy/Alemtuzumab arm of the Phase I BALLI-01 Trial of UCART22- EHA 2022- Poster Presentation
Download the PDF file
16
May 2022
18:22 E.S.T.
Endowing Universal CAR T-cell with Immune-Evasive Properties Using TALEN® -Gene Editing- ASGCT 2022- Oral Presentation
Download the PDF file
11
Apr 2022
15:16 E.S.T.
UCART20x22: First allogeneic dual CAR T-cell therapy for the treatment of B-cell malignancies – AACR 2022 – Abstract
Download the PDF file
10
Apr 2022
20:41 E.S.T.
UCART20x22: First allogeneic dual CAR T-cell therapy for the treatment of B-cell malignancies – AACR 2022 – Poster Presentation
Download the PDF file
Posts pagination
← PREV
1
2
Scientific publications
Discover Cellectis' scientific publications
Learn more